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Another Warning Sign: High Nicotine Content in Electronic Cigarettes
Disrupts Mucociliary Clearance, the Essential Defense Mechanism of
the Lung
Electronic cigarette (e-cigarette) usage has become popular at an
alarming rate and continues to rise, especially among younger
populations in the United States. In 2018 alone, there was anz40%
increase in usage (from 12% to 21%) compared with 2017 among
high school students, according to a recent Centers for Disease
Control and Prevention report (1). Many incorrectly believe that
smoking e-cigarettes (vaping) is not harmful to health. The general
misconception by the public that “e-cigarettes are safe,” however,
has been challenged or overturned by many recent studies revealing
the association between e-cigarettes and adverse cardiovascular,
pulmonary, and systemic health effects.
As a nicotine delivery system, e-cigarette liquids typically
contain 1) a vehicle (propylene glycol/vegetable glycerin [PG/VG]),
2) a chemical that gives an appealing flavor, and 3) various
This article is open access and distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives License 4.0
(http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage
and reprints, please contact Diane Gern (dgern@thoracic.org).
Supported by the NIH/NHLBI/FDA (P50HL120100).
Originally Published in Press as DOI: 10.1164/rccm.201905-1080ED on
June 14, 2019
EDITORIALS
1082 American Journal of Respiratory and Critical Care Medicine Volume 200 Number 9 | November 1 2019
concentrations of nicotine. Previous studies have focused on the
toxic effects of these ingredients either as a whole or as separate
components of e-cigarettes. Using airway epithelial cell lines, Sassano
and colleagues showed that PG/VG itself adversely affected cell
viability, and that certain e-liquids, including the most common ones
on the market, are more toxic than PG/VG alone (2). White blood
cells in the airways, such as neutrophils and macrophages, are crucial
for the innate defense of the airways. However, when they are
exposed to constant stimulation, such as from cigarette smoke, they
can contribute to the initiation and progression of chronic lung
diseases such as chronic obstructive pulmonary disease. It has been
shown that e-cigarettes can also trigger neutrophils and macrophages
to release their enzymes such as elastase and MMP9 (matrix
metalloproteinase 9) (3, 4), which are known to cause tissue damage
in the long run. Furthermore, e-liquids, even without nicotine, can
trigger an inflammatory and oxidative response and cytotoxicity on
the human monocytes (5). Moreover, in vivo human unbiased
proteomics studies using human induced sputum and epithelial cells
derived from human airways from smokers and e-cigarette users
revealed that vaping causes marked adverse changes in the airways,
including altered epithelial and sputum proteomes and
mucus/mucin composition (3, 6) in both a similar and a unique way
relative to cigarette smokers.
Nicotine is a highly addictive substance, and the high level of
nicotine delivered by the current generation of e-cigarette devices
can cause addiction in never-smokers (7) and could subsequently
provide a foundation to start traditional cigarette smoking (8). The
nicotine content of e-cigarettes typically varies between 3 and 36
mg/ml. Most recent generations of e-cigarettes contain much more
nicotine (up to 60 mg/ml), typically in a salt form, to speed up and
increase the delivery of nicotine to the brain at rates comparable to
those found with cigarette smoking. The adverse effect of nicotine
on the airways and its consequences, however, is an understudied
area. As reported in this issue of the Journal, Chung and colleagues
(pp. 1134–1145) addressed this critical issue by performing a
comprehensive mechanistic study using in vivo (sheep) and in vitro
models (human primary bronchial epithelial cell cultures) to observe
lung hemostasis and pathobiology in response to nicotine (9). The
authors previously showed that chronic e-cigarette exposure caused
chronic obstructive lung disease in mice in a nicotine-dependent
manner (10). In this work, they used primary airway epithelial cells
derived from nonsmoking healthy individuals for in vitro exposure
experiments. They then assessed the effects of e-cigarette vapor on
airway cells via sophisticated mucociliary transport (MCT), mRNA
and protein expression, calcium imaging, mucus concentration, and
complex viscosity assays. For in vivo animal (sheep) studies, tracheal
mucus velocity (TMV), a surrogate marker for mucociliary
clearance, was measured after nebulized e-cigarette exposure.
The relative viscosity analysis of cell secretions showed that
compared with an air-only control and e-cigarette vapor with no
nicotine, e-cigarette vapor with nicotine increased mucus viscosity
and decreased the airway surface liquid height in a dose-dependent
fashion. Also, human primary bronchial epithelial cell mucus
concentrations, measured by percent solids, increased approximately
1.5- to 2-fold. Given the fact that increased mucus concentration and
viscosity are inversely related to mucociliary clearance rates, they
measured the MCT in cell cultures. As predicted, MCT was
significantly reduced, by approximately sixfold on average, in the
cultures exposed to nicotine. To understand the mechanism of the
adverse effect of nicotine on the cells, the authors focused on a Ca21-
selective ion channel, TRPA1 (transient receptor potential ankyrin
1), as a possible nicotine receptor. In fact, using known inhibitors of
TRPA1, the authors averted the adverse effects of the nicotine on
airway surface liquid, mucus concentration, and viscosity, which
strongly suggests that the effects of nicotine were transmitted
through TRPA1 and not the nicotinic acetylcholine receptor.
To validate their in vitro observations, the authors used an
in vivo (sheep) exposure model. They found that TMV diminished
by approximately half after exposure to e-cigarette liquid with
15–20 mg/ml nicotine as compared with e-cigarette liquid with
10 mg nicotine or e-cigarette vapor with no nicotine. This effect
was prevented when a TRPA1 inhibitor was added to the mixture,
which is consistent with the cell culture results and confirms that
the nicotine effect occurs via the TRIPA1 receptor. However, this
important in vivo observation (i.e., impaired mucociliary clearance
via nicotine and its consequences) needs to be tested and replicated
in the future in in vivo human studies involving e-cigarette users
with no history of smoking cigarettes. Although this study focused
on certain e-cigarette liquids with nicotine up to 36 mg/ml, some
new e-cigarette devices and some e-liquids contain a much higher
nicotine content and can potentially deliver more nicotine to the
airways (10). Given the nicotine concentration–dependent nature
of the impaired TMV shown here, it can therefore be speculated
that these new devices could be more harmful to the airways.
Mucus abnormalities, such as increased viscoelasticity, elevated
mucus/mucin concentrations, and impaired MCT, are commonly
seen in cigarette smokers with and without chronic bronchitis, and
are closely related to chronic inflammatory muco-obstructive lung
diseases such as chronic obstructive pulmonary disease (11).
Altogether, this important report published by Chung and
colleagues provides novel and unique data showing the harmful
effect of e-cigarettes on mucociliary clearance, a crucial part of the
lungs’ first line of defense. Along with previously reported adverse
effects of e-cigarettes, such as increased oxidative stress, neutrophil
and macrophage activation, impaired and altered innate defense,
and inflammatory response and cytotoxicity, the current findings
provide further convincing evidence that e-cigarette smoking is
harmful to the airways. n
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